AbbVie (XSWX:ABBV) Cyclically Adjusted FCF per Share: CHF9.30 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ABBV AbbVie Inc XSWX:ABBV
76 GF Score
Price CHF211.45
GF Value CHF176.84
! 5 Warning Signs
View Full Analysis

What is AbbVie Cyclically Adjusted FCF per Share?

AbbVie XSWX:ABBV +0.67% 76 Cyclically Adjusted FCF per Share is CHF9.30 as of Jun. 2026. GuruFocus rates XSWX:ABBV with a GF Score™ of 76/100 and a GF Value™ of CHF176.84. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

AbbVie's adjusted free cash flow per share for the three months ended in Jun. 2026 was CHF1.405. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is CHF9.30 for the trailing ten years ended in Jun. 2026.

During the past 12 months, AbbVie's average Cyclically Adjusted FCF Growth Rate was 7.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 14.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of AbbVie was 17.70% per year. The lowest was 10.20% per year. And the median was 14.30% per year.

As of today (2026-08-21), AbbVie's current stock price is CHF211.45. AbbVie's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was CHF9.30. AbbVie's Cyclically Adjusted Price-to-FCF of today is 22.74.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of AbbVie was 23.97. The lowest was 15.05. And the median was 18.63.


AbbVie  (XSWX:ABBV) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

AbbVie's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=211.45/9.30
=22.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of AbbVie was 23.97. The lowest was 15.05. And the median was 18.63.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


AbbVie Cyclically Adjusted FCF per Share Related Terms


AbbVie Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for AbbVie's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie Cyclically Adjusted FCF per Share Chart

AbbVie Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AbbVie Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 8.94 9.30

XSWX:ABBV vs MRK, JNJ, AMGN: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, AbbVie's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where AbbVie's Cyclically Adjusted Price-to-FCF falls into.


XSWX:ABBV
76GF Score
AbbVie Inc XSWX:ABBV
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AbbVie Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AbbVie's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.405/333.9520*333.9520
=1.405

Current CPI (Jun. 2026) = 333.9520.

AbbVie Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.796 241.428 1.101
201612 0.895 241.432 1.238
201703 1.254 243.801 1.718
201706 1.136 244.955 1.549
201709 1.888 246.819 2.555
201712 1.476 246.524 1.999
201803 1.500 249.554 2.007
201806 1.733 251.989 2.297
201809 2.711 252.439 3.586
201812 2.160 251.233 2.871
201903 1.963 254.202 2.579
201906 1.564 256.143 2.039
201909 2.940 256.759 3.824
201912 2.056 256.974 2.672
202003 2.385 258.115 3.086
202006 1.682 257.797 2.179
202009 2.895 260.280 3.714
202012 2.282 260.474 2.926
202103 2.456 264.877 3.096
202106 2.400 271.696 2.950
202109 4.008 274.310 4.879
202112 2.529 278.802 3.029
202203 2.481 287.504 2.882
202206 2.656 296.311 2.993
202209 4.069 296.808 4.578
202212 3.774 296.797 4.246
202303 2.094 301.836 2.317
202306 3.122 305.109 3.417
202309 3.736 307.789 4.054
202312 2.215 306.746 2.411
202403 1.928 312.332 2.061
202406 1.025 314.175 1.090
202409 2.485 315.301 2.632
202412 3.392 315.605 3.589
202503 0.698 319.799 0.729
202506 2.243 322.561 2.322
202509 2.984 324.800 3.068
202512 2.194 324.054 2.261
202603 1.582 330.213 1.600
202606 1.405 333.952 1.405

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of CHF9.30 mean?
AbbVie (XSWX:ABBV) has a Cyclically Adjusted FCF per Share of CHF9.30 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on AbbVie and its competitors.
Is AbbVie's Cyclically Adjusted FCF per Share too high?
AbbVie's current Cyclically Adjusted FCF per Share is CHF9.30. Overall, AbbVie has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does AbbVie's Cyclically Adjusted FCF per Share compare to MRK and JNJ?
AbbVie's Cyclically Adjusted FCF per Share of CHF9.30 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on AbbVie and its competitors. AbbVie's current Cyclically Adjusted FCF per Share is CHF9.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AbbVie stock overvalued right now?
AbbVie (XSWX:ABBV) has a current Cyclically Adjusted FCF per Share of CHF9.30. The stock's GF Value™ is CHF176.84, compared to a current price of CHF211.45 — trading 19.6% above its estimated fair value. The current Cyclically Adjusted FCF per Share is CHF9.30. AbbVie's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For AbbVie (XSWX:ABBV), the current Cyclically Adjusted FCF per Share is CHF9.30 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AbbVie (XSWX:ABBV) Overvalued in 2026?

Based on GuruFocus' analysis, AbbVie stock appears to be overvalued. The current stock price of CHF211.45 is trading 19.6% above its estimated GF Value™ of CHF176.84.

Key valuation signals for XSWX:ABBV:

  • Cyclically Adjusted FCF per Share: CHF9.30
  • GF Value™: CHF176.84 vs. price of CHF211.45 (19.6% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the XSWX:ABBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AbbVie Business Description

Address 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
76GF Score

Get the complete analysis for XSWX:ABBV

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF211.45
Price
CHF176.84
GF Value